HK1034743A1 - Mammalian cell surface antigens, related reagents - Google Patents

Mammalian cell surface antigens, related reagents

Info

Publication number
HK1034743A1
HK1034743A1 HK01104920A HK01104920A HK1034743A1 HK 1034743 A1 HK1034743 A1 HK 1034743A1 HK 01104920 A HK01104920 A HK 01104920A HK 01104920 A HK01104920 A HK 01104920A HK 1034743 A1 HK1034743 A1 HK 1034743A1
Authority
HK
Hong Kong
Prior art keywords
cell surface
mammalian cell
surface antigens
related reagents
reagents
Prior art date
Application number
HK01104920A
Other languages
English (en)
Inventor
Daniel M Gorman
Jeanine D Mattson
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21867133&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1034743(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK1034743A1 publication Critical patent/HK1034743A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK01104920A 1996-12-13 2001-07-14 Mammalian cell surface antigens, related reagents HK1034743A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3284696P 1996-12-13 1996-12-13

Publications (1)

Publication Number Publication Date
HK1034743A1 true HK1034743A1 (en) 2001-11-02

Family

ID=21867133

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01104920A HK1034743A1 (en) 1996-12-13 2001-07-14 Mammalian cell surface antigens, related reagents

Country Status (15)

Country Link
US (5) US6242586B1 (xx)
EP (5) EP1114864B9 (xx)
JP (6) JP2001506991A (xx)
CN (1) CN1245534A (xx)
AT (1) ATE399861T1 (xx)
AU (1) AU5697098A (xx)
BR (1) BR9714401A (xx)
CA (1) CA2274801C (xx)
DE (2) DE69738811D1 (xx)
DK (1) DK1114864T4 (xx)
ES (1) ES2305009T5 (xx)
HK (1) HK1034743A1 (xx)
LU (1) LU91756I2 (xx)
PT (1) PT1114864E (xx)
WO (1) WO1998025958A2 (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US7632922B1 (en) * 1995-12-22 2009-12-15 Amgen, Inc. Osteoprotegerin
EP1114864B9 (en) * 1996-12-13 2013-05-08 Schering Corporation Mammalian cell surface antigens, related reagents
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
EP2371962A3 (en) 1996-12-23 2011-12-21 Immunex Corporation Receptor activator of NF-KAPPA B, receptor is member of TNF receptor superfamily
RU2238949C2 (ru) * 1997-04-15 2004-10-27 Санкио Компани Лимитед Белок, специфически связывающийся с ингибирующим остеокластогенез фактором (ocif) (варианты), днк его кодирующая (варианты), днк в качестве зонда (варианты), способ получения белка (варианты), способ скрининга вещества (варианты), антитело (варианты), способ получения поликлонального антитела, гибридома (варианты), способ получения моноклонального антитела, способ измерения ocif-связывающего белка, фармацевтическая композиция (варианты) и лекарственное средство (варианты)
AU2008200700C1 (en) * 1997-04-15 2013-04-04 Daiichi Sankyo Co., Ltd Novel Protein and Process for Producing The Same
US6316408B1 (en) * 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
US5843678A (en) * 1997-04-16 1998-12-01 Amgen Inc. Osteoprotegerin binding proteins
RO128635A2 (ro) * 1997-04-16 2013-07-30 Amgen Inc. Anticorp sau fragment al acestuia care se leagă la opgbp şi utilizarea acestuia, utilizarea unei forme solubile de odar, şi metodă de identificare a unui compus care descreşte activitatea opgbp
AU2011202547B2 (en) * 1997-04-16 2014-08-28 Amgen Inc. Osteoprotegerin binding proteins and receptors
US6084926A (en) * 1997-12-08 2000-07-04 Ericsson Inc. Method and system for demodulating radio signals
US7063960B2 (en) 1997-12-12 2006-06-20 The Rockefeller University Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
CA2328140C (en) * 1998-05-14 2012-03-13 Immunex Corporation Method of inhibiting osteoclast activity
DK1114166T3 (da) * 1998-09-15 2005-08-01 Pharmexa As Fremgangsmåde til nedregulering af osteoprotegerinligandaktivitet
AU754971B2 (en) * 1998-09-15 2002-11-28 Pharmexa A/S Method for down-regulating osteoprotegerin ligand activity
US20030103978A1 (en) * 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
EP1257648B2 (en) † 2000-02-23 2016-09-14 Amgen Inc. Antagonistic selective binding agents of osteoprotegerin binding protein
DE01973455T1 (de) * 2000-09-22 2004-04-22 Immunex Corp., Seattle Screeningverfahren für agonisten und antagonisten des rezeptoraktivators von nf-kappa b
US7128911B2 (en) * 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
JP4761710B2 (ja) 2002-04-05 2011-08-31 アムジェン インコーポレイテッド 選択的ｏｐｇｌ経路インヒビターとしてのヒト抗ｏｐｇｌ中和抗体
US7462700B2 (en) * 2002-12-10 2008-12-09 Schering-Plough Animal Health Corporation Canine RANKL and methods for preparing and using the same
EP1750761A1 (en) * 2004-06-02 2007-02-14 Cytos Biotechnology AG Medical uses of carrier conjugates of non-human tnf-peptides
US7582910B2 (en) * 2005-02-28 2009-09-01 The Regents Of The University Of California High efficiency light emitting diode (LED) with optimized photonic crystal extractor

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2031216A1 (de) 1969-06-19 1971-01-14 Citizen Watch Co Ltd , Tokio Tag und Datum Stellvorrichtung fur Uhren mit Kalender
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
ATE64618T1 (de) 1982-03-15 1991-07-15 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
ES2118372T3 (es) 1992-11-17 1998-09-16 Icos Corp Nuevos receptores siete transmembrana v28.
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
WO1996031625A1 (en) * 1995-04-07 1996-10-10 Cytogen Corporation Polypeptides having a functional domain of interest and methods of identifying and using same
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6111090A (en) * 1996-08-16 2000-08-29 Schering Corporation Mammalian cell surface antigens; related reagents
EP1114864B9 (en) * 1996-12-13 2013-05-08 Schering Corporation Mammalian cell surface antigens, related reagents
EP2371962A3 (en) * 1996-12-23 2011-12-21 Immunex Corporation Receptor activator of NF-KAPPA B, receptor is member of TNF receptor superfamily
US6271349B1 (en) * 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
RU2238949C2 (ru) * 1997-04-15 2004-10-27 Санкио Компани Лимитед Белок, специфически связывающийся с ингибирующим остеокластогенез фактором (ocif) (варианты), днк его кодирующая (варианты), днк в качестве зонда (варианты), способ получения белка (варианты), способ скрининга вещества (варианты), антитело (варианты), способ получения поликлонального антитела, гибридома (варианты), способ получения моноклонального антитела, способ измерения ocif-связывающего белка, фармацевтическая композиция (варианты) и лекарственное средство (варианты)
US5843678A (en) 1997-04-16 1998-12-01 Amgen Inc. Osteoprotegerin binding proteins
US6316408B1 (en) * 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
RO128635A2 (ro) * 1997-04-16 2013-07-30 Amgen Inc. Anticorp sau fragment al acestuia care se leagă la opgbp şi utilizarea acestuia, utilizarea unei forme solubile de odar, şi metodă de identificare a unui compus care descreşte activitatea opgbp
CA2328140C (en) * 1998-05-14 2012-03-13 Immunex Corporation Method of inhibiting osteoclast activity

Also Published As

Publication number Publication date
ES2305009T5 (es) 2012-11-15
EP1114864A3 (en) 2001-10-10
EP0948530A2 (en) 1999-10-13
EP1995317A1 (en) 2008-11-26
JP2010172336A (ja) 2010-08-12
EP1114864A2 (en) 2001-07-11
EP1114864B2 (en) 2012-07-25
CA2274801A1 (en) 1998-06-18
JP2009254381A (ja) 2009-11-05
US20030144480A1 (en) 2003-07-31
PT1114864E (pt) 2008-10-08
JP2010119397A (ja) 2010-06-03
US20060025572A1 (en) 2006-02-02
US6525180B1 (en) 2003-02-25
ATE399861T1 (de) 2008-07-15
US6242586B1 (en) 2001-06-05
EP1995318A1 (en) 2008-11-26
DK1114864T4 (da) 2012-09-03
BR9714401A (pt) 2000-04-18
EP1803816A3 (en) 2007-09-26
JP2008143906A (ja) 2008-06-26
EP1995317B1 (en) 2014-11-05
JP2013074899A (ja) 2013-04-25
DE122010000046I1 (de) 2011-05-05
DE69738811D1 (de) 2008-08-14
US20090092597A1 (en) 2009-04-09
CA2274801C (en) 2014-02-04
US7063841B2 (en) 2006-06-20
WO1998025958A2 (en) 1998-06-18
JP2001506991A (ja) 2001-05-29
EP1114864B1 (en) 2008-07-02
DK1114864T3 (da) 2008-10-06
LU91756I2 (fr) 2011-01-24
CN1245534A (zh) 2000-02-23
EP1114864B9 (en) 2013-05-08
AU5697098A (en) 1998-07-03
ES2305009T3 (es) 2008-11-01
WO1998025958A3 (en) 1998-07-30
EP1803816A2 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
AU4055697A (en) Mammalian cell surface antigens; related reagents
WO1998027114A3 (en) Mammalian cell surface antigens; related reagents
HK1034743A1 (en) Mammalian cell surface antigens, related reagents
MY157028A (en) Mammalian cytokine, related reagents
WO1997021812A3 (en) Mammalian chemokine ccf8 and chemokine receptor cckr3
WO1995018826A3 (en) Purified primate ctla-8 antigens and related reagents
AU5587298A (en) Isolated mammalian monocyte cell genes; related reagents
WO2000042188A3 (en) Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
WO1998001557A3 (en) Mammalian chemokine reagents
WO1998011226A3 (en) Mammalian chemokines, related reagents
WO1998039421A3 (en) Mammalian proteinases; oxidoreductases; gtp binding proteins; related reagents
AU1825097A (en) Mammalian cx3c chemokine genes
WO1998032858A3 (en) Mammalian chemokines; receptors; reagents; uses
MX9603266A (es) Genes de timocina de mamiferos.
IL130164A0 (en) Mammalian chemokines
EP0997476A3 (en) Antibodies to a mammalian Langerhans cell antigen and their uses
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
EP1867720A3 (en) Purified genes encoding mammalian cell surface antigens; proteins and antibodies
WO1998031810A3 (en) Mammalian chemokines; receptors; reagents; uses
WO1998023747A3 (en) Isolated mammalian dendritic cell genes; related reagents
WO2000034335A3 (en) 'death domain' containing receptors
WO2001009176A3 (en) Mammalian cytokines; related reagents
WO1999019491A3 (en) Human dnax interleukin-40 (dil-40)

Legal Events

Date Code Title Description
AM43 Amendment of standard patent following opposition or revocation proceedings in the designated patent office (acc. sect 43 patent ordinance)
PE Patent expired

Effective date: 20171211